Patent · US Active

Substituted 1,3-dioxanes useful as PPAR modulators

US8536196B2 · kind B2 · utility

2Cited by

19References

19Claims

0Family size

Assignee

EVOLVA SA · CH

Inventors

Alexandra Santana Sorensen · Paseo Los Muchachos, DK
Jean-Philippe Meyer · Strasbourg, FR
Peteris Alberts · Helsingborg, SE
Prathama Satyendra Mainkar · Hyderabad, IN
Melya Hughes Crameri · Los Altos, US
Thierry Bonnaud · Cambridge, GB
Joanne K. Kelleher · Cambridge, US
David Pearson · Lauder, GB

Key dates

Filing date	Jan 18, 2008
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Mar 14, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/113
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.